Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

Comparison of Oropharyngeal Leak Pressures of SaCo Video Laryngeal Mask Airway (LMA) and ProSeal LMA in Adult Elective Surgery

NCT07688590 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-02-01
Last updated
2026-07-07

Condition(s) studied

Oropharengeal Leak Pressure

Investigational drug(s) / intervention(s)

ProSeal LMA Group (Group-P)SaCo Video LMA Group (Group-V)

ProSeal LMA Group (Group-P): Group-P: ProSeal LMA group (n:90). in adult patients scheduled for surgery, airway patency will be maintained with a ProSeal LMA

SaCo Video LMA Group (Group-V): Group-V: SaCo Video LMA group (n:90). in adult patients scheduled for surgery, airway patency will be maintained with a SaCo LMA

Study summary

To compare of oropharyngeal leak pressures of SaCo video laryngeal mask airway (LMA) and ProSeal LMA in adult elective surgery

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Patients scheduled for electvie surgery in the general surgery, gynecology and obstetrics, urology and orthopedics departments * Between 18-65 years * ASA I-II group * Mallampati scores I-II * Patients who will undergo surgery in the supine position * Surgeries with a planned duration of no more than 90 minutes. Exclusion Criteria: * Those who are outside the age range of 18-65 * Those who are ASA III and above * Those who are Mallampati score III-IV * Patients scheduled for emergency surgery * Those whose condition prevents LMA implantation * those who have had an upper respiratory tract infection in the last 4 weeks * those with a body mass index ≥30 kg/m² * those scheduled for laparoscopic surgery

Primary outcome measure(s)

  • Oropharyngeal Leak Pressure — Periprocedural
    The oropharengeal leak pressure will be evaluated by same anaesthetist after LMA placement

Trial sites (1)

FacilityCityRegionStatus
Van Yuzuncu Yil University Van Tusba
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07688590 on ClinicalTrials.gov ↗ ← All trials in Turkey